Clinical TrialsSearch results
Number of results: 535
Recruiting
- Prognostic study of risk stratification among Japanese patients with chronic kidney disease and ischemic heart disease using gated myocardial perfusion SPECT
- Chronic kidney disease, Ischemic heart disease
- Cardiovascular research foundation
- 2009-04-30
Other
- Primary prevention of cerebrovascular and cardiovascular events with an oral antidiabetic agent in patients with type 2 diabetes at high risk for cerebral infarction
- Type 2 Diabetes
- PROFIT-J Study Steering Committee
- 2007-10-09
Other
- Primary Hyperaldosteronism in Japan
- hypertension
- National Hospital Organization
- 2008-02-01
Recruiting
- Preventive effect of Goshajinkigan against CIPN with paclitaxel: an open-label, randomized, phase II study
- Malignant tumor
- Makimoto Go
- 2021-11-02
Recruiting
- Preperation intervention study for colonoscopy
- Chronic constipation
- Kinugasa Hideaki
- 2022-03-18
Recruiting
- Preoperative Immuno-Nutritional Therapy for Lung Cancer
- lung cancer
- Shien Kazuhiko
- 2024-09-02
Other
- Prediction of development of pancreatic necrosis in early stage of severe acute pancreatitis by Perfusion CT ;A multicenter prospective observational Cohort study
- severe acute pancreatitis
- Kyoto University Graduate School of Medicine Department of Gastroenterology and Hepatology
- 2009-06-28
Other
- Post-marketing study of cilostazol: Study to Confirm Efficacy in Preventing Recurrent Cerebral Infarction in Comparison with Aspirin
- Patients with cerebral infarction (excluding cardiogenic cerebral embolism)
- Otsuka Pharmaceutical Co., Ltd.
- 2005-09-13
Other
- PhaseIII study of gefitinib versus cisplatin plus docetaxel in patients with non-small cell lung cancer with EGFR mutation
- non small cell lung cancer
- West Japan Oncology Group
- 2006-12-11
Other
- Phase2 Study of Glivec (imatinib mesylate, formerly known as STI571) in Patients with Relapsed or Refractory Sarcomas with c-kit or PDGFR Expression
- Sarcoma with c-kit or PDGFR expression by immunohistochemistry
- Office of Imatinib phase2 study
- 2005-08-22